Midiana (Drospirenone, Ethinylestradiol)

Drospirenone, the active ingredient in Midiana, is a combined oral contraceptive presented as a tablet for oral use. Together with ethinylestradiol, it works to prevent pregnancy by inhibiting ovulation and altering cervical mucus in women of reproductive age through hormonal regulation of the hypothalamic‑pituitary‑ovarian axis.

GNH USA supplies Midiana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory support for global distribution. Midiana is manufactured in accordance with EU GMP guidelines, ensuring consistent potency and safety for patients.

Midiana, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual disorders. - Pregnancy prevention: provides reliable contraception for women of childbearing age. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Dysmenorrhea relief: reduces painful menstrual cramps. - Acne improvement: may lessen androgen‑dependent acne in some users. - Management of heavy menstrual bleeding: contributes to reduced menstrual blood loss.

Midiana may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or soreness. - Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: blood clots in deep veins or lungs. - Hypertension: new or worsening high blood pressure. - Liver dysfunction: abnormal liver enzyme elevations or jaundice.

Before prescribing Midiana, clinicians should consider several safety factors. - Assess cardiovascular risk: evaluate personal or family history of thrombosis. - Avoid smoking: contraindicated in women over 35 who smoke. - Monitor blood pressure: check regularly during therapy. - Review concomitant medications: consider drugs that affect hepatic enzymes. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Midiana can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine): may reduce contraceptive efficacy. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase hormone levels and risk of side effects. - Anticoagulants (e.g., warfarin): may heighten thrombosis risk.

Moderate Interactions (Monitor Closely): - Rifampin and other potent antibiotics: may lower contraceptive effectiveness. - St. John’s wort (herbal supplement): may decrease hormone concentrations. - Thiazide diuretics: may affect blood pressure control while on the pill.